🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lucid Diagnostics Inc.

LUCD Healthcare
$1.01 +$0.02 (2.07%)
Market Cap: $192.86 M
Gurus Holding
3
Popularity Rank
#2679
% of Shares Held
0.48%
Net Activity (Q2 2026)
+$203,374.9

Guru Ownership Trend

Guru Analysis for Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Inc. (LUCD), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $933,745.

Top institutional holders include Cliff Asness and Jefferies Group.

Institutional sentiment is currently Bullish. This is evidenced by a $203,374.9 net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 208.1%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 85.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$661,721.17
Total Buy Value
New Buys 1
Additions 1
-$458,346.27
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Lucid Diagnostics Inc. (LUCD)

Major holders include Cliff Asness ($773,824), Jefferies Group ($139,100), Renaissance Technologies (RenTech) ($76,291). According to the latest reported data, 3 tracked investment managers collectively hold approximately 924,500 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $203,374.9, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited LUCD. The total reported sell value was $458,346.27.

Yes, 1 managers opened new positions in LUCD, and 1 increased their existing holdings. The total reported buy value was $661,721.17.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 208.1% 723,200 $773,824 Q2 2026
0.00% New Buy 130,000 $139,100 Q2 2026
0.00% Reduce -85.7% 71,300 $76,291 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form